Pulmonx (LUNG) Change in Account Payables (2019 - 2025)

Pulmonx (LUNG) has reported Change in Account Payables for 7 consecutive years, with $121000.0 the latest figure, recorded in Q3 2025.

• On a quarterly basis, Change in Account Payables fell 91.02% year-over-year to $121000.0 in Q3 2025; TTM through Sep 2025 was $2.1 million, a 61.41% increase from a year earlier, with the FY2024 full-year figure at $2.3 million, up 760.29% from the prior year.
• Change in Account Payables was $121000.0 for Q3 2025 at Pulmonx, down from $2.1 million in the prior quarter.
• Over five years, Change in Account Payables peaked at $2.6 million in Q3 2021 and troughed at -$2.8 million in Q4 2021.
• A 5-year average of $264894.7 and a median of $121000.0 in 2025 frame the typical range for Change in Account Payables.
• Across the five-year window, Change in Account Payables tumbled 2111.11% in 2022 and soared 42900.0% in 2025, its largest moves.
• Over 5 years, Change in Account Payables stood at -$2.8 million in 2021, then jumped by 70.54% to -$830000.0 in 2022, then sank by 104.58% to -$1.7 million in 2023, then soared by 58.78% to -$700000.0 in 2024, then jumped by 117.29% to $121000.0 in 2025.
• The last three Change in Account Payables figures came in at $121000.0 (Q3 2025), $2.1 million (Q2 2025), and $505000.0 (Q1 2025), per Business Quant data.